About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT03604549

Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)

Performing fluoroscopic HSG with oil based contrast medium has been shown to increase pregnancy rates in a subfertile population. This is a pilot study to test the efficacy of as well as the tolerabil...

Lead sponsor: Milton S. Hershey Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Milton S. Hershey Medical Center

Collaborators

Guerbet

Age

18 - 40 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Eligible for Sono HSG for fertility testing
•In good general health
•Willing and capable of complying with the study procedures
•At least one patent tube and no endometrial pathology on Sono HSG
•Ready to undergo infertility treatment immediately after the test
•Not planning on IVF therapy in the next 6 mos

Exclusion Criteria

•Known tubal or endometrial (polyp, submucous fibroid, etc.) pathology
•At high risk for tubal disease due to history of Pelvic Inflammatory Disease
•Known hypersensitivity to Lipiodol UF®or known allergy to iodine containing contrast media or shellfish
•Endometrial pathology on Sono HSG requiring further evaluation (as per the performing physician)
•Bilateral tubal occlusion on Sono HSG
•Unable to tolerate potential pain associated with the study.
•Requiring IVF due to severe male factor, known pelvic adhesions, etc.
•Couples with decreased male factor fertility rate (i.e., low sperm count or motility, i.e. less than 5 million/mL concentration on semen analysis

Related studies

Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?

NCT05969574 · Infertility, Female, Miscarriage, and more

Quantifying Uterine Elastography in Menstruating Women

NCT06816381 · Infertility (IVF Patients), Infertility Assisted Reproductive Technology

Interest of Sperm Insemination at 42 Hours Post hCG Compared to 36h in Intrauterine Insemination

NCT06804538 · Infertility, Intrauterine Insemination (IUI)

Aromatherapy for Mental Health Promotion in IVF Patients

NCT07480668 · Anxiety, Stress, and more

Biological Aging Hallmarks-Guided Integrative TCM and Conventional Medicine in Post-Treatment Unexplained Female Infertility

NCT07404969 · Idiopathic Infertility, Infertility Unexplained, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 2, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment58

Start dateJan 2019

Last updatedMay 2, 2022

Condition

Locations shown

Penn State Milton S. Hershey Medical Center

Hershey, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 2, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions